Meeting
2023 ASCO Genitourinary Cancers Symposium
The genomic landscape of TERT alterations in bladder cancer.
Authors
Aimee Jalkanen
Exact Sciences Corp, Phoenix, AZ
Aimee Jalkanen , Gargi D. Basu , David W. Hall , Jess R Hoag , Janine R. LoBello , Frederick L. Baehner , Snehal Govind Thakkar , Tanya B. Dorff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 551)
DOI
10.1200/JCO.2023.41.6_suppl.551
Abstract #
551
Poster Bd #
M14
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Circulating tumor DNA analysis of genomic alterations in metastatic urothelial carcinoma from NCT03113266 study.
First Author: Haige Chen
Poster
2024 ASCO Genitourinary Cancers Symposium
Genomic profiling of bladder cancer in waterpipe and cigarette smokers: Implications for carcinogenicity and genetic landscape.
First Author: Ali Shamseddine
Poster
2023 ASCO Annual Meeting
Penile squamous cell carcinoma (PSCC) with elevated tumor mutational burden (TMB): A genomic landscape study.
First Author: Rebecca A Sager
Poster
2022 ASCO Annual Meeting
Landscape of fibroblast growth factor receptor (FGFR) genomic alterations (GA) in urothelial bladder cancer (UBC).
First Author: Maroun Bou Zerdan